Use of persantin to reduce microaggregation in the pump oxygenation.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects*; D004176:Dipyridamole / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D005112:Extracorporeal Circulation / Q000009:adverse effects; D005337:Fibrin; D006355:Heart-Lung Machine / Q000009:adverse effects; D066298:In Vitro Techniques; D008833:Microcirculation; D010477:Perfusion; D010973:Platelet Adhesiveness / Q000187:drug effects; D011652:Pulmonary Circulation
D004176:Dipyridamole; D005337:Fibrin